Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. (Q42980109)
Jump to navigation
Jump to search
scientific article published on 10 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. |
scientific article published on 10 July 2008 |
Statements
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients (English)
L Falcato
S Dober
B Helbling
O Keiser
F Negro
D Meili
Swiss Hepatitis C Cohort Study